sponsored content
March 4, 2024
In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the PROTECT randomized controlled trial (RCT) for NaturalVue Multifocal.
The PROTECT RCT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) is being conducted to determine NaturalVue’s effect controlling myopia progression.
Watch the video to learn more about the PROTECT one-year results for NaturalVue Multifocal’s ability to control myopia progression and find out how many children in the trial experienced no myopia progression at all during the first year.
